Skip to main content
. 2021 Oct 2;9(10):2086. doi: 10.3390/microorganisms9102086

Figure 1.

Figure 1

Effect of EPS-1 administration on DSS-induced colitis symptoms. (A) Changes in body weight (%), (B) Colon length (cm), (C) DAI score, and (D) MPO activity (U/g). Data are presented as mean ± SD. ## p < 0.01 vs. the NC group, * p < 0.05 and ** p < 0.01 vs. the DSS group by using one-way analysis of variance, followed by the Duncan’s test.